E2730

DRUG4 trials

Sponsors

Eisai Inc.

Conditions

Healthy ParticipantsHealthy VolunteersPhotosensitive Epilepsy

Phase 1

Study to Assess the Safety, Tolerability, and Pharmacokinetics of E2730

CompletedNCT03054194

Eisai Inc.Healthy Participants

Start: 2017-01-31End: 2017-03-02Updated: 2018-09-07

A Study to Assess the Safety, Tolerability, and Pharmacokinetics of E2730 in Healthy Participants

CompletedNCT03451890

Eisai Inc.Healthy Participants

Start: 2018-02-09End: 2018-09-26Updated: 2019-03-04

A Study to Assess the Safety and Tolerability of E2730 After Multiple Dose and the Food Effect After Single Dose in Healthy Participants

CompletedNCT04676685

Eisai Inc.Healthy Volunteers

Start: 2020-12-16End: 2021-06-23Updated: 2021-08-26

Phase 2

A Study to Evaluate the Pharmacodynamic Activity of E2730 in Adult Participants With Photosensitive Epilepsy

TerminatedNCT03603639

Eisai Inc.Photosensitive Epilepsy

Start: 2018-07-27End: 2019-02-14Updated: 2022-05-04